Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Pharmaceutical"


25 mentions found


AUSTRALIAIt has agreed to buy 135 million doses: 34 million from AstraZeneca, 40 million from Novavax Inc, 10 million from Pfizer and 51 million from CSL Ltd. It expects delivery of 3.8 million doses of AstraZeneca’s vaccine in January and February next year. It hopes to lock in 60 million doses in total and also is in talks with Pfizer and Sinovac. BANGLADESHBangladesh signed a deal with India’s Serum to buy 30 million doses of the AstraZeneca vaccine. It also expects to receive 68 million doses from GAVI at a subsidized rate, a senior health ministry official said.
Persons: Dado, Sputnik, Johnson Organizations: Reuters, Pfizer Inc, Moderna Inc, AstraZeneca Plc, REUTERS, AstraZeneca, Novavax Inc, Pfizer, CSL Ltd, Western, Shenzhen Kangtai Biological, Shanghai Fosun Pharmaceutical Group, Tibet Rhodiola Pharmaceutical, Johnson, Shionogi, Co, SOUTH, drugmakers, Serum Institute of India, Sputnik, Sinovac, India’s Locations: AUSTRALIA, CHINA China, China, Shenzhen, Shanghai, Tibet, China . China, JAPAN Japan, Japan, SOUTH KOREA, COVAX, India, TAIWAN Taiwan, PHILIPPINES, Philippines, INDONESIA, Indonesia, VIETNAM, BANGLADESH Bangladesh
FILE PHOTO: German Economic Cooperation and Development Minister Gerd Mueller attends the weekly cabinet meeting at the Chancellery in Berlin, Germany September 16, 2020. But with richer countries ordering up supplies, concerns have grown that poorer nations will miss out. Gerd Mueller, Germany’s development minister, said it should not only be richer governments trying to make sure the developing world gets its fair share. “Private companies that have particularly profited from the coronavirus crisis, like Amazon or the pharmaceuticals companies also have an obligation,” he told Reuters. Pharmaceutical firms should offer the World Health Organization’s COVAX initiative - designed to make available supplies to poorer countries - “the best possible conditions and good prices” for their vaccines, Mueller said.
Persons: Gerd Mueller, Michael Sohn, , Angela Merkel, Mueller Organizations: Economic Cooperation, REUTERS BERLIN, , Reuters, Pharmaceutical Locations: Berlin, Germany, United States
Surgeon General Jerome Adams on Tuesday pleaded with Americans to grasp “the severity of the moment” and remain vigilant against the coronavirus pandemic, as record hospitalizations pushed healthcare professionals to the brink. Case rates in the 12 Midwestern states are more than double that of any other region, according to the COVID Tracking Project, up more than 20 times from mid-June to mid-November. Some are repurposing areas to accommodate COVID-19 patients or cramming multiple patients in a single room, and are asking staffers to work longer hours and more frequent shifts. Michigan reported over 4,000 hospitalized COVID-19 patients on Monday, surpassing its previous record on April 13. “A quarter of all of our coronavirus cases this year have occurred in the last month.
Persons: Jerome Adams, We’ve, ” Adams, , Kelly Cawcutt, COVID, Organizations: Reuters, U.S, Coronavirus, Force, Fox News, Global, Pharmaceuticals, University of Nebraska Medical Center Locations: U.S, United States, COVID, America, Michigan
(Reuters) - State and federal officials pleaded with Americans to stay at home and redouble efforts to curtail the coronavirus pandemic on Tuesday, defending unpopular public health measures as record hospitalizations pushed healthcare professionals to the brink. “We are on fire with COVID,” Kentucky Governor Andy Beshear said on CNN after enacting new restrictions last week including retail curbs and school closures. That has taxed already exhausted healthcare providers as more than 1,500 coronavirus deaths and 171,000 new cases pile up daily on average. U.S. health officials last week strongly recommended that Americans avoid travel for the holiday. “Stay home, stay protected and keep yourself and others well,” the Mississippi State Department of Health said in a tweet on Tuesday.
Persons: Andy Beshear, We’re, Jerome Adams, ” Adams, Adams, , Kelly Cawcutt, Gunderway, Organizations: Reuters, CNN, United, U.S, Coronavirus, Force, Fox News, Pharmaceuticals, U.S . Food, Drug Administration, University of Nebraska Medical Center, Mississippi State Department of Health Locations: ” Kentucky, COVID, U.S, Texas, El Paso, America, Mississippi, Massachusetts, North Carolina, Connecticut
(Reuters) - Officials pleaded with Americans to stay at home and redouble efforts to curtail the coronavirus pandemic on Tuesday, defending unpopular public health measures as record hospitalizations pushed medical professionals to the brink. HOW TO JUST SAY ‘NO’California’s top health official, Dr. Mark Ghaly, went so far in his weekly public COVID briefing on Tuesday to offer up “COVID chat” talking points for politely but firmly declining invitations to family gatherings that might be unsafe. After an initial wave of infections centered in and around major U.S. cities during the spring, the COVID-19 pandemic now has engulfed rural and small-town America. “Stay home, stay protected and keep yourself and others well,” the Mississippi State Department of Health said in a tweet on Tuesday. Not all Americans were throwing caution to the wind for the holiday.
Persons: Andy Beshear, We’re, Jerome Adams, , ” Adams, Adams, Mark Ghaly, ” Ghaly, Greg Abbott, , Kelly Cawcutt, Jerard Gunderway Organizations: Reuters, CNN, U.S, Fox News, American Automobile Association, U.S . Centers for Disease Control, Regeneron Pharmaceuticals Inc, University of Nebraska Medical Center, Mississippi State Department of Health Locations: ” Kentucky, COVID, Texas, El Paso, U.S, America, Mississippi, Massachusetts, North Carolina, Connecticut
The vaccine's creator, Sarah Gilbert, had faith in its efficacy from the start: Her triplets participated in the UK trial. The UK trial included three notable participants: the triplets of the vaccine's creator, Sarah Gilbert. As young adults in their 20s, Gilbert's children fit the typical profile of a vaccine trial volunteer. A UK coronavirus vaccine trial. Kirsty O'Connor/PA Images via Getty ImagesThe UK trial resumed less than a week later, after local regulators determined it was safe to do so.
Persons: Sarah Gilbert, Gilbert, , Rob Blundell, Caitlin, Susannah, Freddie, Merve Emre, coronavirus, Kirsty O'Connor, Oxford, didn't, Moderna's Organizations: AstraZeneca, University of Oxford, Pharmaceutical, Bloomberg, Oxford, University of Bath, Twitter, BBC, Food and Drug Administration, Pfizer, Moderna Locations: Brazil, China, COVID
The following is a preview of one Digital Health report, the AI in Drug Discovery and Development Report. AI & Machine Learning in the Drug Development ProcessAn incredible amount of time and money goes into drug development — bringing a drug to market costs about $2.8 billion dollars over 12+ years, according to Taconic Biosciences' tally. AI in Drug Discovery (Phase I)The drug discovery process ranges from reading and analyzing already existing literature, to testing the ways potential drugs interact with targets. According to Insider Intelligence' AI in Drug Discovery and Development report, AI could curb drug discovery costs for companies by as much as 70%. AI in Preclinical Development (Phase 2)The preclinical development phase of drug discovery involves testing potential drug targets on animal models.
Persons: brawn, Eli Lilly Exscientia, Roche, Roche Sanofi TriNetX Organizations: Intelligence, Digital Health, pharma, Amazon Pharmacy, Machine, Taconic Biosciences, FDA, Pharma Investments, Moderna, Big Tech, Apple AstraZeneca, Microsoft Moderna Novartis Otsuka Pfizer, Pharmaceuticals, Roche Sanofi, Roche Sanofi TriNetX Verily
FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid(Reuters) - U.S. government will begin distributing Regeneron Pharmaceuticals Inc’s newly authorized COVID-19 antibody combination therapy starting Tuesday, beginning with over 30,000 courses, a health official said during a media call on Monday. The U.S. Food and Drug Administration on Saturday issued emergency use authorization for the antibody cocktail to be used for the treatment of mild to moderate COVID-19 in adults and children who are at high risk of progressing to severe COVID-19.
Persons: Brendan McDermid Organizations: Regeneron Pharmaceuticals, REUTERS, Pharmaceuticals, U.S . Food, Drug Administration Locations: Westchester, Tarrytown , New York, U.S
Slideshow ( 2 images )(Reuters) - The U.S. government will start distributing Regeneron Pharmaceuticals Inc’s newly authorized COVID-19 antibody combination on Tuesday, beginning with over 30,000 treatment courses, a health official said on Monday. The antibody cocktail was among the treatments given to U.S. President Trump during his bout with COVID-19 last month. U.S. regulators earlier this month authorized another antibody treatment for COVID-19 from Eli Lilly and Co. Officials on Monday said the department of Health and Human Services has already helped distribute 120,000 doses of Lilly’s antibody to patients around the country. More than 250,000 Americans have also been treated for their COVID-19 with antibody-rich convalescent plasma from recovered patients, officials said. Some health experts have argued that there is not enough data to show that convalescent plasma is an effective treatment.
Persons: Regeneron, Trump, , Eli Lilly Organizations: U.S, Regeneron Pharmaceuticals, U.S . Food, Drug Administration, Health, Human Services Locations: ., U.S, COVID
Futures rise as vaccine progress fuels recovery hopes
  + stars: | 2020-11-23 | by ( Reuters Staff | ) www.reuters.com + 0.00   time to read: +2 min
(Reuters) - U.S. stock index futures rose on Monday as hopes that the first COVID-19 vaccine could be available within weeks renewed bets of a swift economic recovery next year. FILE PHOTO: The New York Stock Exchange (NYSE) is seen as people walk in silhouette in the financial district of New York, U.S., November 19, 2020. Global equity markets received a boost earlier on Monday as AstraZeneca Plc became the latest major drugmaker to say its COVID-19 vaccine could be around 90% effective, although its shares fell 1.8% as some traders perceived the efficacy data as disappointing compared with rivals. ET, Dow e-minis were up 142 points, or 0.49%, S&P 500 e-minis were up 15.25 points, or 0.43%, and Nasdaq 100 e-minis were up 30 points, or 0.25%. In company news, shares of drugmaker Regeneron Pharmaceuticals Inc jumped 5.7% in premarket trading after the FDA on Saturday granted emergency use authorization to its COVID-19 antibody therapy.
Persons: Shannon Stapleton, BioNTech, , Philip Shaw, Steven Mnuchin Organizations: Reuters, New York Stock Exchange, REUTERS, . Food, Drug Administration, Pfizer Inc, Global, AstraZeneca Plc, Investec, Dow e, Nasdaq, Sunday, Federal Reserve, drugmaker Regeneron Pharmaceuticals Inc, FDA Locations: New York, U.S, United States, London, Nevada
(Reuters) - Wall Street’s main indexes were set to rise on Monday as hopes that the first COVID-19 vaccine could be available within weeks renewed bets of a swift economic recovery next year. ET, Dow e-minis were up 170 points, or 0.58%, S&P 500 e-minis were up 19.25 points, or 0.54%, and Nasdaq 100 e-minis were up 39 points, or 0.33%. Market participants warned of higher volatility in a trading week shortened by the Thanksgiving holiday on Nov. 26. By contrast, the growth index, which comprises heavyweight technology stocks, has risen less than 8% in November after leading Wall Street’s recovery from its coronavirus lows. But traders are again turning cautious about the economic damage from the coronavirus-led restrictions to contain a surge in infections.
Persons: Shannon Stapleton, BioNTech, , Peter Cardillo, Steven Mnuchin Organizations: Reuters, New York Stock Exchange, REUTERS, . Food, Drug Administration, Pfizer Inc, Global, AstraZeneca Plc, Spartan Capital Securities, Dow e, Nasdaq, drugmaker Regeneron Pharmaceuticals Inc, FDA, Merck, Co Locations: New York, U.S,
(Reuters) - Wall Street’s main indexes rose on Monday as hopes of a COVID-19 vaccine and data showing a rapid expansion in monthly business activity fueled bets of a quicker economic recovery from a pandemic-driven recession. FILE PHOTO: The New York Stock Exchange (NYSE) is seen as people walk in silhouette in the financial district of New York, U.S., November 19, 2020. “It isn’t like the vaccine is going to be distributed tomorrow. Advancing issues outnumbered decliners 3.67-to-1 on the NYSE and 1.75-to-1 on the Nasdaq. The S&P index recorded 26 new 52-week highs and no new low, while the Nasdaq recorded 125 new highs and seven new lows.
Persons: Shannon Stapleton, , , Hogan, Peter Cardillo, Steven Mnuchin Organizations: Reuters, New York Stock Exchange, REUTERS, National Securities, Dow Jones, Nasdaq, Global, AstraZeneca Plc, Spartan Capital Securities, , drugmaker Regeneron Pharmaceuticals, FDA, NYSE Locations: New York, U.S
LONDON — Pharmaceutical company AstraZeneca said Monday late-stage trials of its Covid-19 vaccine have shown it to be “highly effective” in preventing disease. In another dosing regiment, when two full doses were administered, the vaccine was 62 percent effective, researchers said, resulting in combined average efficacy of 70 percent. Earlier this month, Pfizer and Moderna reported preliminary results from late-stage trials, showing that their vaccine candidates were almost 95 percent effective. "Incredibly exciting news the Oxford vaccine has proved so effective in trials," he said in a tweet. AstraZeneca already has international agreements in place to supply three billion doses of the vaccine, the company said.
Persons: “ We’ve, Andrew Pollard, Pascal Soriot, Boris Johnson Organizations: — Pharmaceutical, AstraZeneca, NBC, University of Oxford, Covid, Pfizer, Moderna, British, World Health Organization Locations: Oxford, Brazil, South Africa, U.S, Kenya, Russia, Japan, India, Europe
Merck acquires OncoImmune to ramp supply of promising Covid drug
  + stars: | 2020-11-23 | by ( Meg Tirrell | ) www.cnbc.com + 0.00   time to read: +4 min
Pharmaceutical giant Merck said it plans to acquire privately-held OncoImmune for $425 million in cash, gaining rights to an under-the-radar drug that's shown striking results in hospitalized patients with Covid-19. The data, in 203 patients, also showed that patients receiving CD24Fc had a 60% higher probability of seeing improved clinical status. "If you look at the other anti-inflammatories that have been studied in very ill Covid-19 patients, it's been hard to show there's any effect at all." In addition to the potential to help with the pandemic, Merck acquired OncoImmune because it sees possibilities for CD24Fc beyond Covid-19. But Merck only gains CD24Fc; OncoImmune will spin out other rights and assets into a new company, into which Merck will invest $50 million.
Persons: Merck, CD24Fc, Roger Perlmutter, Perlmutter, he's, Yang Liu, Moncef Slaoui, Slaoui, it's, It's, That's Organizations: Pharmaceutical, Merck, University of Maryland School of Medicine, U.S . Food, Drug Administration Locations: U.S, Covid, ICUs, United States
Merck shares added 1.9% in premarket trading as of 7:31 a.m. The shares rose 6% in premarket trading as of 7:31 a.m. The shares were volatile in premarket trading and slightly lower as of 7:31 a.m. Regeneron rose 4% in premarket trading as of 7:31 a.m. Pfizer (PFE) – Pfizer's Covid-19 vaccine could receive U.K. approval this week, according to a report by the Telegraph news site.
Persons: – Merck, Korn Ferry, – Regeneron, Regeneron, Pfizer's, BioNTech, – Needham, , Patrick Ky, WU, Eli Lilly, – Lilly, Locker, Piper Sandler, Piper, Foot, WestJet, Blackstone, Kellogg Organizations: Merck, Revenue, AstraZeneca, Oxford University, Regeneron Pharmaceuticals, Food and Drug Administration, Pfizer, Telegraph, FDA, Boeing, European Union Safety Agency, Paris Air Forum, Federal Aviation Administration, Western Union, Saudi Arabia's STC Group, Delta Air Lines, DAL, U.S, New, LaGuardia, Blackstone, Bloomberg, , Suisse Locations: Canada, Asia
OncoImmune founder on Merck acquiring the company to ramp up supply of Covid-19 drugPharmaceutical giant Merck said it plans to acquire privately-held OncoImmune for $425 million in cash, gaining rights to an under-the-radar drug that's shown striking results in hospitalized patients with Covid-19. Dr. Yang Liu, founder, CEO and chief scientific officer of Oncolmumune, joins "Squawk Box" to discuss the drug as well as the reason for the acquisition.
Persons: Yang Liu Organizations: Merck, Pharmaceutical
FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/(Reuters) - The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease. bit.ly/3kTd6fRThis includes those who are 65 years of age or older or who have certain chronic medical conditions. The treatment is part of a class of drugs known as monoclonal antibodies, which are manufactured copies of antibodies created by the human body to fight infections. The FDA said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19.
Persons: Brendan McDermid, Donald Trump, Regeneron’s, Regeneron Organizations: Regeneron Pharmaceuticals, REUTERS, U.S . Food, Drug Administration, FDA Locations: Westchester, Tarrytown , New York, U.S, COVID
Xi says China ready to boost global COVID-19 vaccine cooperation
  + stars: | 2020-11-21 | by ( Reuters Staff | ) www.reuters.com + 0.86   time to read: +1 min
FILE PHOTO: Chinese President Xi Jinping arrives for the meeting to commend role models in China's fight against the coronavirus disease (COVID-19) outbreak, at the Great Hall of the People in Beijing, China September 8, 2020. REUTERS/Carlos Garcia RawlinsBEIJING (Reuters) - President Xi Jinping said on Saturday that China is ready to step up global COVID-19 vaccine cooperation, and called for better international coordination on policies to facilitate movement of people. Pharmaceutical companies and research centres around the world are working on potential COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants underway. “China is willing to strengthen cooperation with other countries in the research and development, production, and distribution of vaccines,” Xi told the G20 Riyadh Summit via video link. With that in mind, Xi said China would propose the creation of a mechanism by which travellers’ coronavirus test results were recognised internationally through digital health codes.
Persons: Xi Jinping, Carlos Garcia Rawlins, ” Xi, , Xi, Organizations: of, People, REUTERS, Carlos Garcia Rawlins BEIJING, Pharmaceutical Locations: Beijing, China
FDA Authorizes Regeneron’s Covid-19 Antibody Cocktail Drug
  + stars: | 2020-11-21 | by ( Joseph Walker | ) www.wsj.com sentiment -0.97   time to read: 1 min
Regeneron Pharmaceuticals Inc.’s Covid-19 antibody drug was authorized Saturday by U.S. health regulators, the second cleared this month to treat patients who aren’t hospitalized but are at high risk of developing severe disease. The Food and Drug Administration cleared the antibody drug cocktail for use treating mild to moderate Covid-19 patients 12 years of age and older, including people older than 65 years. Regeneron’s...
Organizations: Regeneron Pharmaceuticals Inc, Drug Administration
The r ecent news of two promising coronavirus vaccines has led more employers to begin seriously thinking about vaccination policies at the workplace. Labor and unemployment lawyers have seen a flood of the same inquiry from clients across various industries: Can they make it mandatory for employees to get vaccinated for the coronavirus? With the prospect of a coronavirus vaccine drawing sooner than many had initially expected, labor and employment lawyers are seeing a surge in clients asking the same question: Is it legal to make workplace COVID-19 vaccinations mandatory? The most common question that clients are asking: Can you make it mandatory for employees to get a coronavirus vaccine? A very likely uptick in work for labor & employment lawyers given the many unknownsLike many things about the coronavirus, there still remains a lot of unknowns with the vaccines.
Persons: they've, Jimmy Robinson, Ogletree Deakins, Ogletree, Robinson, Read, Karla Grossenbacher, Grossenbacher, Michael Roche, Strawn, Thomas Wassel, Cullen, Dykman, imminently, Nathaniel Glasser, Epstein Becker Green, Glasser, There's, Ogletree's Robinson, haven't, Guy Brenner, Proskauer's, Brenner, Joe Biden Organizations: Labor, Pharmaceutical, Pfizer, Moderna, Employers, Business, Opportunity Commission, Winston, Occupational Safety, Health Administration, OSHA Locations: Washington , DC, Long, Washington ,
Housing and Urban Development Secretary Ben Carson said he is feeling better after a weekslong battle with the coronavirus. Carson said he used an extract from a toxic plant to fight the disease, at the recommendation of MyPillow CEO Mike Lindell. Housing and Urban Development Secretary Ben Carson said on Friday that he is "out of the woods" after fighting the coronavirus using an unproven treatment. Carson tested positive for the virus earlier this month, after having attended a White House election watch party. Dr. Anthony Fauci, the nation's top infectious disease specialist, said he actively avoids going to the White House because "of all the infections there."
Persons: Ben Carson, Carson, Mike Lindell, Lindell, Oleander, Donald Trump, Trump, Regeneron, Walter Reed, Anthony Fauci Organizations: Urban, White, Facebook, Food and Drug Administration, FDA, White House, . Pharmaceutical, Pfizer, Moderna, Johns Hopkins University
Xi says China ready to boost global vaccine cooperation
  + stars: | 2020-11-21 | by ( Nbc News | ) www.nbcnews.com + 0.82   time to read: +1 min
Xi says China ready to boost global vaccine cooperationBEIJING — President Xi Jinping said on Saturday that China is ready to step up global Covid-19 vaccine cooperation, and called for better international coordination on policies to facilitate movement of people. Pharmaceutical companies and research centers around the world are working on potential Covid-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants underway. "China is willing to strengthen cooperation with other countries in the research and development, production, and distribution of vaccines," Xi told the G20 Riyadh Summit via video link. He also called for stronger international policy coordination to establish travel "fast tracks" that would facilitate orderly global movement. With that in mind, Xi said China would propose the creation of a mechanism by which travelers' coronavirus test results were recognized internationally through digital health codes.
Persons: Xi, Xi Jinping Organizations: BEIJING —, Pharmaceutical Locations: China, BEIJING
U.S. surpasses more than 12 million Covid cases
  + stars: | 2020-11-21 | by ( Nbc News | ) www.nbcnews.com + 0.00   time to read: +5 min
SEE NEW POSTSU.S. surpasses more than 12 million Covid cases The United States topped 12 million cases of Covid-19 on Saturday, as the third wave's uncontrolled spread prompted the Centers for Disease Control and Prevention to urge Americans not to travel for Thanksgiving. The country recorded more than 200,000 coronavirus cases over the last 24 hours, bringing the total to 12,002,863, according to NBC News' tally. Of those, a dozen states are seeing a spike in new cases. Share this -Donald Trump Jr.: 'Apparently I got the ‘Rona' Donald Trump Jr, gave a casual assessment of his situation on social media Friday night in first comments since his Covid-19 diagnosis was reported. President Donald Trump tweeted Saturday morning, "My son Donald is doing very well.
Persons: Xi, Xi Jinping, Donald Trump, Trump, confectioner Laszlo Rimoczi's, BERNADETT SZABO, confectioner Laszlo, Rimoczi, Putin, Vladimir Putin, Donald Trump Jr, Rona, Donald Organizations: Centers for Disease Control, NBC News, Washington D.C, U.S ., BEIJING —, Pharmaceutical, Trump, Trump National Golf Club, White, Reuters, Sputnik, Trump Jr Locations: States, Washington, Puerto Rico, U.S, U.S . Virgin Islands, Guam, China, BEIJING, Sterling , Virginia, Hungary, Russia
Cannabis companies have an eventful four years ahead of them. Exchange-traded funds tracking the space have also soared over that time frame, with one of the biggest gainers being the Amplify Seymour Cannabis ETF (CNBS), up nearly 23%. "We're the only derivative-free cannabis ETF that's up year to date," with a nearly 15.5% gain as of Friday's close, Seymour said. The ETFMG Alternative Harvest ETF (MJ), the largest pot ETF by assets under management, is down over 22% for 2020. So, that's really what we're doing at CNBS," Seymour said.
Persons: Joe Biden, Tim Seymour, CNBS, CNBC's, Seymour, Read Organizations: Aurora, Cronos, Exchange, Cannabis ETF, Seymour Asset Management, GW Pharmaceuticals
Russian President Vladimir Putin wants to distribute its questionable Sputnik V coronavirus vaccine to other countries, Reuters reported Saturday. The Kremlin also kept important information relevant to the vaccine's success out of the public's eye. Russian President Vladimir Putin said Saturday that the country is hoping to distribute its controversial Sputnik V coronavirus vaccine to other countries, according to Reuters. Russia announced a successful coronavirus vaccine in August, but Sputnik V was approved under questionable circumstances. There are two coronavirus vaccines that have proven to have a high success rate at fighting the coronavirus.
Persons: Vladimir Putin, Sputnik, Susie Neilson, Putin, White Organizations: Reuters, Sputnik, Food and Drug Administration, Saturday, Kremlin, . Pharmaceutical, Pfizer, Moderna Locations: Russia, Russian, United States
Total: 25